Pneumonia
📧 Sign up to get email alerts when something new happens for Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Evaluation of Linezolid Administered Intravenously in MRSA-positive, Morbidly Obese Patients With Pneumonia [Phase 4]
Phase 4 pharmacokinetic and pharmacodynamic study evaluating intravenous linezolid in MRSA-positive, morbidly obese patients with pneumonia …
-
CLINICAL_TRIALS trial_result · 2021-11-30Clinical Trial Update: Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) [Phase 3]
Phase 3 trial update for OVERCOME evaluating treatment of extensively drug-resistant gram-negative infections; study completed with results …
-
FDA approval · 2021-11-18FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved vancomycin hydrochloride as a generic drug under an Original Application from Slate Run Pharmaceuticals, LLC.
-
FDA approval · 2021-11-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (Plano Pharmaceuticals Inc.)
The FDA approved a supplemental application for Vancomycin hydrochloride by Plano Pharmaceuticals Inc., approving changes to the approved dr…
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly [NA]
A completed clinical trial evaluating the role of imaging and microbiology in diagnosing pneumonia in the elderly.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-10-26FDA Approved: ZYVOX — Supplemental Application (Pharmacia & Upjohn Company LLC)
The FDA approved a supplemental application for Zyvox (linezolid) from Pharmacia & Upjohn Company LLC.
-
CLINICAL_TRIALS trial_result · 2021-10-13Clinical Trial Update: An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 [Phase 3]
Phase 3 randomized trial evaluating the combination of Dalargin with Leitragin for severe and critical SARS-CoV-2 infections has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Steroid Dosing by bioMARker Guided Titration in Critically Ill Patients With Pneumonia [Phase 2]
Phase 2 trial update on steroid dosing guided by bio-marker titration in critically ill pneumonia patients; results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-05Clinical Trial Update: Nebulized Heparin for the Treatment of COVID-19 [Phase 4]
Phase 4 trial update investigating nebulized heparin for the treatment of COVID-19, with completed status.
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: A Study of LY3127804 in Participants With COVID-19 [Phase 2]
Phase 2 clinical trial of LY3127804 in COVID-19 patients was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-08-11Clinical Trial Update: Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation [Phase 2]
Phase 2 clinical trial evaluating mavrilimumab to reduce progression of acute respiratory failure in COVID-19 pneumonia with systemic hyper-…
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) [Phase 2, Phase 3]
A clinical trial update on antithrombotic therapy to reduce complications in COVID-19, spanning Phase 2 and Phase 3, with completed status.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Inhalation Low Dose Radionuclide Therapy in Treatment COVID-19 [Phase 1, Phase 2]
Phase 1/2 clinical trial of inhalation low-dose radionuclide therapy for COVID-19 and related pneumonia completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 [Phase 2, Phase 3]
Clinical trial update for Yinhu Qingwen Granula in treating severe COVID-19 has suspended its Phase 2/Phase 3 studies.
-
CLINICAL_TRIALS trial_result · 2021-06-22Clinical Trial Update: FX06 to Rescue Acute Respiratory Distress Syndrome During Covid-19 Pneumonia [Phase 2]
Phase 2 clinical trial update evaluating FX06 to rescue acute respiratory distress syndrome in COVID-19 pneumonia.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Tocilizumab for Patients With Cancer and COVID-19 Disease [Phase 2]
Phase 2 trial evaluating tocilizumab in cancer patients with COVID-19 was terminated; results were posted in June 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Clinical Use of Stem Cells for the Treatment of Covid-19 [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating the clinical use of stem cells for Covid-19 and related pneumonia, including multiple organ failure, …
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Effectiveness Trial of Day-care vs. Usual Care of Severe Pneumonia & Malnutrition in Children [Phase 4]
Phase 4 trial update comparing Day-care versus usual care for severe pneumonia and malnutrition in children; status unavailable.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation [Phase 2]
Phase 2 trial evaluating mavrilimumab to reduce progression of acute respiratory failure in COVID-19 pneumonia with systemic hyper-inflammat…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 [Phase 3]
Phase 3 clinical trial evaluating the efficacy of chloroquine or hydroxychloroquine in treating pneumonia caused by SARS-CoV-2/COVID-19 has …
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: SILtuximab in Viral ARds (SILVAR) Study [Phase 3]
Phase 3 trial of SILtuximab in viral ARDS (SILVAR) was terminated.
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia [Phase 2]
Phase 2 trial evaluating efficacy and safety of a treatment relative to standard of care in patients with COVID-19 pneumonia; current status…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Comparative Therapeutic Efficacy and Safety of Different Antiviral and Anti Inflammatory Drugs in COVID-19 Patients. [Phase 4]
Phase 4 trial update comparing antiviral and anti-inflammatory drugs in COVID-19 patients with pneumonia.
-
FDA approval · 2021-03-16FDA Approved: PIPERACILLIN AND TAZOBACTAM — Supplemental Application (Eugia US LLC)
The FDA approved a supplemental application for Piperacillin and Tazobactam (piperacillin sodium and tazobactam sodium) submitted by Eugia U…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer [Phase 4]
Phase 4 clinical trial evaluating observation and treatment of pulmonary microthrombosis in childhood pneumonia with elevated D-dimer; study…